News Results
There are 798,590 News Results
May 30, 2017
PLAINSBORO, N.J., May 31, 2017 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for REBINYN(®) (Coagulation Factor IX...
May 31, 2017
CAMBRIDGE, Mass., June 1, 2017 /PRNewswire/ -- IBM Watson Health (NYSE: IBM ) and its collaborators today unveiled data that will be presented at ASCO 2017, demonstrating the clinical utility...
Jun 4, 2017
TORONTO, June 5, 2017 /CNW/ - When it comes to telecommunications, Canadian consumers deserve the best. The Government of Canada will encourage the advancement of telecommunication services by focusing on...
Jun 5, 2017
Collection Features A Revamped Smart Streaming Experience Coming This Summer with VIZIO SmartCast TV(SM)
Jun 5, 2017
BEAVERTON, Ore., June 6, 2017 /PRNewswire/ -- Tektronix, Inc., a leading worldwide provider of measurement solutions, has again broken through the innovation barrier with the introduction of the new 5...
Jun 6, 2017
WASHINGTON, June 7, 2017 /PRNewswire-USNewswire/ -- After receiving a record-breaking number of applications to join an exciting future of space exploration, NASA has selected its largest astronaut class since 2000....
Jun 8, 2017
CLEVELAND, June 9, 2017 /PRNewswire/ -- Select Restaurants today said that a recent data security incident at its third-party vendor may have compromised the security of payment information of some...
Jun 9, 2017
SAN DIEGO, June 10, 2017 /PRNewswire-USNewswire/ -- Teens with type 1 diabetes (T1D) who adhere to frequent communication through a two-way text messaging system were found to maintain or improve...
Jun 11, 2017
SAN DIEGO, June 12, 2017 /PRNewswire-USNewswire/ -- Adolescents and young adults with type 1 diabetes benefit from a structured transition program when changing from pediatric to adult diabetes care, resulting...
Jun 11, 2017
SAN DIEGO, June 12, 2017 /PRNewswire/ -- Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two basal insulins, Tresiba(®) (insulin...
